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Abstract
A successful infection of the human intestine by enteropathogenic bacteria depends on the ability of bacteria to
attach and colonize the intestinal epithelium and, in some cases, to invade the host cell, survive intracellularly and
disseminate from cell to cell. To accomplish these processes bacteria have evolved an arsenal of molecules that are
mostly secreted by dedicated type III secretion systems, and that interact with the host, subverting normal cellular
functions. Here we overview the most important molecular strategies developed by enteropathogenic Escherichia
coli, Salmonella enterica, Shigella flexneri, and Yersinia enterocolitica to cause enteric infections. Despite having
evolved different effectors, these four microorganisms share common host cellular targets.
Introduction
Diarrhea-causing pathogens employ a variety of sophisti-
cated strategies to colonize the intestinal epithelium. In
essence, ingested pathogens have evolved the abilities to:
(1) resist non-specific host defenses, such as stomach
acidity, peristalsis, mucosal cell exfoliation, intestinal
mucins, and bacteriocins [1]; (2) adhere to intestinal
epithelia; and (3) ultimately colonize the epithelia. Colo-
nization may, or may not, involve cellular invasion.
When cellular invasion occurs, it can be followed either
by intracellular multiplication and spread of the bacteria
to other tissues, or by bacterial persistence.
Although bacterial pathogens employ different strate-
gies, they share common targets in the host cell and
often cause the same cellular responses. Virulence fac-
tors act either from the extracellular milieu mimicking
cell ligands, or are injected into the intracellular milieu,
where they act in concert to manipulate signaling path-
ways, for example to subvert the plasticity of the cytos-
keleton, interrupt the endocytic traffic, and, in some
cases, mediate resistance to phagocytosis. The host cell,
in turn, defends itself against infection by initiating an
inflammatory response and by altering the intestinal
fluid balance in order to extrude the unwanted bacteria,
thus causing diarrhea. Hence, the success of infection
depends on host cell-bacteria interactions, and in each
step bacteria exploit the target cell machinery for their
own benefit.
Adhesion
Adhesion is the preliminary step in the infectious pro-
cess and requires strong and specific interactions. Table
1 lists the best characterized adhesins in the diarrhea-
causing bacteria discussed in this review, and their cog-
nate host-cell receptors. Bacterial attraction to intestinal
epithelia is also favored by local environmental factors
such as alkaline milieu, humidity and anaerobiosis.
Enteropathogenic Escherichia coli (EPEC)
In response to the first contact with an epithelial cell,
typical EPEC produce adhesive structures called bundle-
forming pili (BFP) and form microcolonies that increase
bacterial resistance to host defenses and are involved in
the localized adherence pattern [2] (Fig. 1a, upper
panel). Colonization of the intestinal epithelia by EPEC
also involves activation of the T3SS. Type III Secretion
Systems are essential Gram-negative virulence determi-
nants believed to mediate the transport of virulence fac-
tors from the bacterial cytoplasm into host cells. The
four pathogens discussed in this review secrete their
virulence factors through a T3SS. Each complex is com-
p o s e do fm o r et h a nt w e n t yp r o t e i n s ,i n c l u d i n gi n t e g r a l
* Correspondence: fabiana.horn@ufrgs.br
1Departamento de Biofísica, Universidade Federal do Rio Grande do Sul, P.O.
Box 15005, 91501-970, Porto Alegre, Brazil
Reis and Horn Gut Pathogens 2010, 2:8
http://www.gutpathogens.com/content/2/1/8
© 2010 Reis and Horn; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.membrane proteins, chaperones and accessory proteins.
They are divided into two substructures: a bacterial
membrane-embedded base and an extracellular needle-
like filament, often called a translocon, through which
effector proteins are injected [3]. Transport of effector
proteins from the bacterial cytoplasm to the periplasmic
space is accomplished at the expense of ATP. Once in
the host cell cytoplasm, these effector proteins interact
with eukaryotic pathways to alter host cell signal
transduction.
Most T3SS-secreted effector proteins are encoded by a
pathogenicity island called locus of enterocyte efface-
ment (LEE). EPEC T3SS translocon is constituted by
EPEC secreted protein A (EspA), one of the first bacter-
ial proteins secreted by the bacteria, that forms a fila-
mentous extension from the bacterium to the surface of
microvilli and acts in conjunction with EspB and EspD
to form a pore structure in the host cell. The translocon
permits translocation of other LEE effector proteins.
The intimate adherence of EPEC - there is only 10 nm
between bacterium and enterocyte - is promoted by an
adhesin called intimin [2]. I n t i m i ni sa no u t e r - m e m -
brane protein encoded by the eae gene in the LEE, and
shares functional and structural homologies to the Yersi-
nia pseudotuberculosis invasin protein [4,5]. The intimin
receptor (Tir), also encoded by the LEE, is translocated
by the T3SS and inserted into the host cell membrane, a
dimer of Tir binds two intimin molecules [4]. Apart
from its receptor function, Tir is phosphorylated on tyr-
osine residues by redundant host kinases [6], and this
phosphorylation depends on Esps and T3SS [5]. Once
phosphorylated, Tir binds Nck, a host protein that
recruits and activates the amino-terminal domain of the
Wiskott-Aldrich syndrome protein (N-WASP), which in
turn recruits and activates actin-related protein 2/3
(Arp2/3). This results in actin filament nucleation
1 (see
Appendix), leading to assembly of pedestal-like struc-
tures beneath the bacterium, typical of EPEC and enter-
ohemorragic E. coli (EHEC), and formation of an
attachment/effacement (A/E) lesion [7] (Fig. 1a, lower
panel). Other effectors involved in microvilli effacement
and pedestal formation are Map, EspF, EspG, EspH and
EspZ, highlighting the complexity of these pathogenic
processes [8]. Although the phosphorylation on tyrosine
residues is sufficient for actin nucleation and lesion for-
mation, Tir is also phophorylated on serine residues by
host protein kinase A and this seems to be necessary for
efficient pedestal formation [9]. Cholesterol in the host
cell membrane also has a crucial function in EPEC
adhesion, since cholesterol depletion reduces bacterial
adherence and A/E lesion formation [10].
The diarrhea observed in EPEC infections probably
results from several mechanisms, including loss of
absorptive surface due to microvilli effacement,
increased intestinal permeability and active ion secre-
tion. Nevertheless, it is not known if these mechanisms
result from the action of EPEC virulence effectors or are
consequences of host-cell responses to bacterial adher-
ence [7]. A report indicates that EPEC is able, in a
T3SS-dependent mechanism, to quickly inhibit in vitro
sodium/glucose cotransporter (SGLT-1) activity even
before microvilli effacement and pedestal formation.
This is a key diarrheagenic mechanism, given that
SGLT-1 is responsible for the daily uptake of approxi-
mately 6 liters of fluids from the intestine [8]. Another
report, which employed the A/E pathogen Citrobacter
rodentium in a mouse infection model, proposed that
the localization of aquaporins (water channels) in colo-
nocytes of the infected mice is altered during infection,
in a process partially dependent on EspF and EspG [11].
For both EPEC and C. rodentium,t h e r ei sg r o w i n ge v i -
dence that these pathogens target and disrupt epithelial
tight junctions, thus contributing to the loss of ions and
water during diarrhea [12]. Moreover, using the C.
rodentium mouse model, Higgins and colleagues (1999)
[13] have shown that intimin plays a dual role in EPEC
pathogenesis: in addition to its function as a cellular
ligand, it drives a Th1 pro-inflammatory response
Table 1 Bacterial adhesive structures and their cognate receptors
Pathogen Adhesin Receptor Effect on host cell Reference
EPEC BFP
EspA
Intimin
Not fully elucidated
Not fully elucidated
Tir
Activation of T3SS
1 and formation of A/E
2 lesions and changes of
epithelial cell morphology
[2,4]
Salmonella
sp.
FimA
FimH
Mannosylated proteins in
epithelial cells
Activation of T3SS and transport of effector proteins necessary for
invasion
[14]
Shigella sp. Complex
IpaB/C
IpaB
Integrin a5 b1
CD44 (natural receptor of
hyaluronic acid)
Activation of T3SS and transport of effector proteins necessary for
invasion
[18,19]
Yersinia sp. Invasin
YadA
b1 integrins (natural receptor of
fibronectin)
Activation of T3SS and transport of effector proteins necessary for
invasion and/or apoptosis
[44]
1. T3SS: Type III Secretion System.
2. A/E lesion: attaching/effacing lesion.
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Throughout the course of the infection, EPEC remain
extracellular and the hyperplasia seems to offer suffi-
cient area for new colonization.
Salmonella enterica
The initial interaction between Salmonella and the gut
epithelium is believed to occur preferentially through M
(Microfold) cells, either from Peyer patches or from
solitary intestinal lymphoid tissue (SILT), which is scat-
tered along the small intestine. M cells are follicle-asso-
ciated epithelium (FAE) cells that function in antigen
sampling; their basolateral surface is invaginated to form a
pocket-like structure, to which macrophages and lympho-
cytes can migrate and where they interact with antigenic
particles.
There is evidence that Salmonella sp. fimbriae play an
important role in attachment to the gut mucosa. Type 1
Figure 1 Pathogenic mechanisms of (a) enteropathogenic E. coli (EPEC) and (b) Salmonella enterica. (a) EPEC contact gut epithelial cells,
produce BFP (upper panel), and activate their T3SS (lower panel). The bacterium translocates the receptor for its adhesin, intimin, called Tir,
through the T3SS into the host cell cytoplasm; the interaction between intimin and Tir promotes tight adhesion. After being phosphorylated by
host kinases, the Tir binds Nck, which activates N-WASP, which in turn activates Arp2/3, leading to actin nucleation and formation of a pedestal
beneath the bacterium. (b) Salmonella interacts with M cells (upper panel), activates its T3SS and translocates SipA and SipC. SipC localizes to
the plasma membrane, where it aids in the translocation of other Salmonella effectors and initiates actin nucleation. The C-terminal domain
nucleates actin and the N-terminal domain of SipC bundles it, anchoring the resulting actin filaments to the cell surface below the bacterium.
The injected SipA acts in synergy with SipC, as SipA binds to and stabilizes the F-actin filaments, and blocks the action of ADF/cofilin (lower
panel). SopE1, SopE2 and SopB activate the RhoGTPases that regulate actin polymerization; SopE1 and SopE2 do so directly by acting as GEFs,
and SopB indirectly by interfering with inositol phosphate metabolism. The activated RhoGTPases induce cytoskeletal rearrangements that result
in bacterial uptake. SptP then switches off the RhoGTPases, and the eukaryotic cell regains its normal shape. Salmonella replicates inside the
vacuole (upper panel).
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tive bacteria; FimA and FimH are encoded by the fim
operon, and the Salmonella genus contains at least
another ten operons that encode fimbrins which, when
expressed, act like adhesins [14]. Mutants in which
genes involved in fimbrin biosynthesis were inactivated
had their virulence attenuated [15]. Salmonella also con-
tains non-fimbrial adhesins, encoded by chromosomal
Salmonella pathogenicity island 4 (SPI-4), of which the
best characterized so far is SiiE, implicated in invasion
at the apical side of polarized epithelial cells [16].
Shigella flexneri
Very little is known about the adhesion structures that
account for the initial contact between Shigella and a
target cell. In contrast to other enteropathogenic bac-
teria that adhere to the small intestine, Shigella exhibits
tropism for the colonic and rectal epithelia. This phe-
nomenon could be explained by preferential adherence
to human colonic mucin instead of small intestinal
mucin observed in Shigella dysenteriae 1 [17]. Also, the
fact that this binding was not inhibited by the presence
of monosaccharides suggests that the receptor of Shi-
gella adhesin is not a simple sugar.
In Shigella, the bacterial proteins responsible for adhe-
sion are the same as those that initiate the process of
invasion. Following adherence, Shigella initiate activation
of T3SS and secretion of effector proteins into the host
cell (Fig. 2a). The genes encoding the translocon itself
and the effector proteins, including four bacterial cha-
perons, are located in a 31-kb pathogenicity island
within a large virulence plasmid (213 kb).
The protein IpaB binds to the receptor for hyaluronic
acid, CD44, while IpaB complexed with IpaC binds to
the fibronectin receptor, a5b1 integrin [18,19]. The com-
plex IpaB/C then forms a structure resembling a pore
inserted into the host cell membrane [20]; the pore links
the T3SS translocon to the eukaryotic cell cytoplasm,
and allows rapid delivery of other effector proteins (Fig.
2a). Apparently, the binding of IpaB to cholesterol pre-
sent in lipid rafts is required for pore formation [21].
Shigella attracts membrane rafts to its site of entry, and
these rafts tend to harbor signaling proteins, many of
which will be targeted by the bacterium. The effector
IpaD localizes to the tip of the T3SS needle; it has been
suggested that this protein is involved in recognition
and contact with the host membrane and controls the
release of other effectors [22].
Yersinia enterocolitica
After being ingested, Yersinia colonize the intestinal
epithelium of the terminal portion of the ileum and pro-
liferate in the underlying lymphoid tissue. Two non-fim-
brial adhesins are crucial for adherence of Yersinia to
host cells: invasin, encoded by the chromosomal gene
inv,a n dY a d A( Yersinia adhesin A), encoded by the Yer-
sinia virulence plasmid (pYV). Invasin is an outer mem-
brane protein that binds a subset of b1 integrins (a3b1,
a4b1,a 5b1,a 6b1 and avb1) through its extracellular, C-
terminal, portion. Although invasin lacks an RGD
domain and shares no sequence homology with fibronec-
tin, the natural ligand of b1 integrins, it binds a5b1 in the
same residues and with a 100-fold higher affinity than
fibronectin [23]. While b1 integrins are restricted to the
basolateral surface of enterocytes [24], M cells express
them on their apical surface, where they are available for
bacterial adherence. The interaction of invasin with an
integrin causes the agglomeration of integrin receptors
over the bacteria-host interface, thus accounting for the
“zipper” mechanism of Yersinia internalization observed
by scanning electron microscop y .I nc o n t r a s tt oi n v a s i n ,
YadA binds diverse extracellular matrix components,
such as collagen, laminin and fibronectin, thus indirectly
mediating integrin binding [25] (Fig. 2b).
Cellular Invasion
Following adhesion, infection by Salmonella, Shigella
and Yersinia involves internalization, a process induced
by the bacteria themselves. EPEC, in contrast, remain
extracellular, although some reports point to an ability
to invade due to the action of the effector protein EspG,
which presumably interacts with tubulin [26], like the
VirG protein of Shigella (see below).
In this section, we will consider the major mechan-
isms by which Salmonella, Shigella and Yersinia trigger
their own uptake.
Salmonella enterica
Following adhesion between Salmonella and host epithe-
lial cell or M cell, the T3SS encoded by chromosomal
Salmonella pathogenicity island 1 (SPI-1) is activated.
The bacterium then injects at least 12 effectors that
trigger bacterial uptake.
Samonella inner proteins (Sip) A and C are probably
the first proteins delivered through the T3SS to the host
cell [27](Fig.1b). Within the host cell, SipC localizes to
the plasma membrane, where it aids in the translocation
of other Salmonella effectors and initiates actin nuclea-
tion. The C-terminal domain nucleates actin and the N-
terminal domain of SipC bundles it, anchoring the
resulting actin filaments to the cell surface below the
bacterium [28]. The injected SipA acts in synergy with
SipC, as SipA binds to and stabilizes the F-actin fila-
ments, and physically blocks the action of an actin
depolymerising factor (ADF/cofilin).
The Salmonella outer proteins (Sop) E (SopE1 and
SopE2), SopB and SptP are also delivered (in a SipC-
dependent way) through the T3SS translocon into the
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brane [27]. SopE and SopE2 act as guanine exchange
factors (GEFs) for the Rho monomeric GTPases RhoG,
Rac1 and Cdc42 [29], which are involved in the forma-
tion of filopodia extensions and lamellipodia structures.
SopB (also known as SigD) also activates Cdc42, by a
poorly understood mechanism, and RhoG by activating
the endogenous GEF [30]. SopB is an inositol
polyphosphate phosphatase that interferes with
phosphoinositide phosphate and inositol phosphate
metabolism [31]: SopB eliminates phosphatidylinositol-
3,5-biphosphate (PtdIns(3,5)P2), PtdIns(4,5)P2 and
PtdIns(3,4,5)P3, generating PtdIns(3)P at the site of bac-
terial invasion; PtdIns(3)P is probably the activator of
the GEF for RhoG, and is retained in the Salmonella-
containing vacuole [32].
Figure 2 Pathogenic mechanisms of (a) Shigella flexneri and (b) Yersinia enterocolitica. (a) Shigella interacts preferentially with M cells in the
colonic and rectal epithelia (upper panel), activates its T3SS and secretes IpaB and IpaC to form a pore inserted into the host cell membrane (lower
panel). The bacterium then delivers effector proteins through the translocon to the eukaryotic cell cytoplasm. IpaC also activates RhoGTPases that,
together with activated Src, recruit cortactin, involved in actin filament reorganization. VirA promotes microtubule destabilization, leading to
activation of RhoGTPases. IpgD generates PI(5)P, thus promoting cell survival through Akt. IpaA binds to vinculin and induces actin
depolymerization. Once inside the host cell, Shigella leaves the vacuole for the cytoplasm and escapes to neighboring cells (upper panel). (b)
Yersinia adheres initially to M cells (upper panel) by means of its adhesins: invasin, which binds b1 integrins directly; and YadA, which binds b1
integrins indirectly through fibronectin (lower panel). The interactions between the adhesins and integrins cause bacterial internalization following
activation of FAK, Rac-1 and Src, which are involved in subtle actin cytoskeletal rearrangements. The vacuole containing the bacterium is
transported towards the basolateral side of the M cell, where it is expelled into the dome region of the FAE (upper panel). When Yersinia interacts
with phagocyte integrins, the T3SS is activated and a set of effector proteins (Yops) are translocated into the phagocyte cytoplasm. Yops are
involved in the antiphagocytic and anti-inflammatory mechanisms used by Yersinia that lead to the formation of microabcesses in the FAE.
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leads to activation of WASp, which, complexed with
monomers of globular actin and Arp2/3, initiates nuclea-
tion of actin and its polymerization into actin filaments.
The induced cytoskeletal rearrangements cause mem-
brane ruffling and culminate in macropinocytosis of bac-
teria by the host epithelial cell [33]. The fact that
Salmonella mutants defective in SopE, SopE2 or SopB
remain invasive and only mutants lacking all three pro-
teins display a non-invasive phenotype illustrates the
redundancy of the Salmonella infection mechanisms [31].
Takeuchi (1967) had already observed that the
e p i t h e l i a lc e l ls o o nr e c o v e r sits normal shape following
macropinocytosis of bacteria. This recovery is brought
about by the effector protein SptP, which acts as a
GTPase-activating factor for the RhoGTPases targeted
by the SopE and SopB proteins, thereby switching off
the signal [34].
Shigella flexneri
After having formed a pore in the membrane of M or
epithelial cells, the IpaB/C complex triggers the initial
events in actin polymerization. The C-terminal domain
of IpaC activates Cdc42, which in turn activates Rac1,
thereby inducing the formation of filopodial and lamelli-
podial extensions [35]. Shigella also somehow activates
t h et y r o s i n ek i n a s eS r c( p p 6 0c), which is implicated
in recruitment by phosphorylation of actin-associated
proteins such as cortactin [36].
The receptor for hyaluronic acid, CD44, once acti-
vated by IpaB, recruits ezrin to the site of entry. Ezrin
recruitment seems to depend on Rho, whose activation
is enhanced by the IpaB-CD44 complex [37]. Ezrin
associates with F-actin and functions as a membrane-
cytoskeleton linker in the filopodial structures. Together,
tyrosine kinases and small GTPases reorganize the actin
cytoskeleton into entry structures similar to the focal
adhesions in the host cell.
VirA is a protein encoded by a virulence plasmid and
secreted in an Ipa-independent manner; it interacts with
and destabilizes a/b-tubulin heterodimers, probably sti-
mulating Rac-1 activity, which thus promotes the forma-
tion of lamellipodial structures around bacterial entry
foci [38].
Two other T3SS-secreted proteins are IpgD and IpaA.
IpgD is a phosphatase with homology to SopB/SigD of
Salmonella; it generates PtdIns(5)P from PtdIns(4,5)P2
at the site of entry, and PtdIns(5)P in turn activates the
PI-3 kinase/Akt pathway, thus contributing to cell survi-
val [39]. IpaA complexes with the focal adhesion protein
vinculin, and induces vinculin capping activity at the
fast growing ends of F actin, thus promoting F actin
depolymerization [40].
These events are summarized in Fig. 2a.
Yersinia enterocolitica
Activation of integrin receptors by invasin and/or YadA
triggers several intracellular signals, which are very simi-
lar to the events that precede cell division: the cytoplas-
mic tail of b1 chain interacts with focal adhesion kinases
(FAKs), Src and the Rac-1-Arp2/3 complex, which in
turn trigger slight cytoskeleton rearrangements needed
for bacterial uptake [41] (Fig. 2b, lower panel). This
clustering or zipper mechanism of invasion contrasts
with the trigger mechanism used by Salmonella and
Shigella.
Yersinia species also hijack host cell phosphoinositide
metabolism for their uptake. Rac-1 recruits, and Arf6
activates, the type I phosphatidylinositol-4-phosphate-5-
kinase (PtdIns(4)P(5)Ka), which forms PtdIns(4,5)P2 at
the entry site, where PtdIns(4,5)P2 may regulate phago-
cytic cup formation by coordinating membrane traffic
and controlling F-actin production [42].
Yersinia internalized by M cells remains intracellular,
bounded by a polymerized actin-coated vacuole. The
bacterium survives inside the vacuole, even though it
does not replicate. This vacuole is then transported
from the apical to the basolateral side of the M cell,
where the bacterium is expelled and exposed to the
dome region of the FAE, which is densely populated by
dendritic cells, macrophages and lymphocytes (Fig. 2b,
upper panel). In this way, Yersinia crosses the epithelial
barrier. However, Yersinia species have evolved a dual
strategy for avoiding destruction and establishing infec-
tion: an antiphagocytic and an anti-inflammatory
strategy.
When Yersinia invasin interacts with phagocyte integ-
rins, the extracellular adherent bacteria transfer a set of
pathogenic factors, known as Yops (Yersinia outer pro-
teins) through a pYv-encoded T3SS to the target cell,
and this inhibits the uptake of Yersinia by interrupting
the phagocytic pathway [43]. The T3SS apparatus is
necessary for injection of the effectors (YopE, YopP,
YopT, YopH, YopO and YopM) into the host cell [44].
Three translocator proteins are known to be required
for the injection: YopB, YopD, which are believed to
form a pore in the host cell membrane, and LcrV (also
called V-antigen), which is localized to the tip of the
needle and acts as a scaffold protein for the correct
insertion of the pore formers in the membrane [45].
LcrV is also an important anti-inflammatory agent,
which has been implicated in suppression of NF-B and
interferon-g and the secretion of inhibitory interleukin
IL-10 by macrophages [46].
YopH, YopE, YopT and YopO act indirectly on the
actin cytoskeleton. YopH is a tyrosine phosphatase that
dephosphorylates several macrophage proteins involved
in focal adhesion, so opposing the phagocytic pathway
induced by the invasin-integrin interaction [47].
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signaling pathway induced by invasin-integrin binding,
thereby inhibiting their degranulation [46]. YopE has
GAP activity and there is evidence that it selectively
inactivates Rac but not Rho or Cdc42 [48]. This inhibi-
tion of Rac activity ultimately leads to the arrest of
membrane ruffling, otherwise an important step in
engulfment. Aili and colleagues have shown that Yersi-
nia devoid of YopE has high levels of Yop translocation
into HeLa cells. This suggests that the GAP activity of
YopE is also important in the modulation of pore for-
mation, since YopE plays a role as a feedback inhibitor
of Yop translocation [49]. YopT also has an anti-phago-
cytic role, since it removes the geranylgeranylated
C-terminal cysteine of RhoA; once this occurs the
enzyme is released from the plasma membrane and
inactivated, so preventing actin reorganization [50]. The
effector protein YopO, also known as YpkA (Yersinia
protein kinase A), possesses a C-terminal actin-binding
domain necessary for YopO activation, and a domain
that mimics Rho and Rac guanine nucleotide dissocia-
tion inhibitors (GDI) [51] and maintains these factors in
their GDP-bound inactive states, while its N-terminal
region harbors a domain with serine/threonine kinase
activity that phosphorylates a critical serine residue on
Gaq protein, blocking downstream calcium signaling
[52]. Apparently, both the GDI and kinase activities of
YopO are involved in disruption of the host
cytoskeleton.
YopM, in contrast, has no enzymatic domain; instead
it acts like a scaffolding protein, regulating the activity
of two host cell kinases, PRK2 and RSK1, both involved
in pathways signaling cell survival and proliferation.
Association of YopM with PRK2 increases its kinase
activity, which in turn activates RSK1. Once activated,
the YopM-kinase complex may phosphorylate a still
unknown substrate [53].
YopP, a homologue of YopJ, orchestrates an anti-
inflammatory process by exerting an inhibitory effect on
both the mitogen-activated protein kinase (MAPK) and
NF-B signaling pathways [54]. YopJ has an acetyl trans-
ferase activity that modifies the activation loop of the
MAPK and Ibk i n a s e s
2 (see Appendix), thereby pre-
venting their phosphorylation and subsequent activation
[55]. Inhibition of the MAPK and NF-B signaling path-
ways results in rapid apoptosis of the macrophages,
which is important for establishing a systemic infection.
In addition to their action on cell adhesion, the sur-
face factors YadA and Ail may be involved in serum
resistance, probably by capturing the C4b-binding pro-
tein that down-regulates the classical and lectin comple-
ment pathways [56]. Later in infection, when Yersinia
interacts with epithelial cells, Yersinia invasin is able to
stimulate NF-B synthesis and trigger the production of
pro-inflammatory cytokines, such as IL-8, via MAPK.
The YadA-ECM-b1 interaction also leads to IL-8 pro-
duction, although this occurs via a different MAPK [57].
IL-8 and other cytokines activated by Yersinia are che-
moattractants and promoters of PMNs and macro-
phages. These cells are recruited to infection sites,
leading to disruption of the epithelial barrier, and expos-
ing the integrins localized on the basolateral sides of
enterocytes, causing bacterial dissemination [57]. Ulcera-
tion and necrosis of the tissue subjacent to the FAE are
also characteristic of Yersinia infections. Systemic disse-
mination begins 24-48 h after infection and may be
enhanced by bacterial phagocytosis; the bacteria travel
through the bloodstream towards the spleen and liver,
w h e r et h e yr e p l i c a t ei nm i c r o abscesses, forming micro-
colonies resistant to phagocytosis.
Intracellular Lifestyle
Here we will discuss how intracellular Salmonella and
Shigella avoid being digested; while Salmonella remains
in the vacuole and adapts to the harsh environment,
Shigella escapes from the phagosome into the cytoplasm
and neighboring cells.
Salmonella enterica
Once intracellular, either in M cells, epithelial cells or
phagocytes, Salmonella is enclosed in an acidic com-
partment called a Salmonella-containing vacuole (SCV),
in which the bacterium alters the endocytic pathway in
order to avoid being destroyed, and replicates.
As mentioned above, Salmonella invasion is accompa-
nied by the formation of PtdIns(3)P and disappearance
of PtdIns(4,5)P2 at the site of entry due to the action of
SopB [32]. PtdIns(4,5)P2 depletion improves actin depo-
lymerization and facilitates membrane fluidity. The local
region of membrane invaginates to form PtdIns(3)P-
enriched vacuoles; PtdIns(3)P recruits early endosomal
markers, including the GTPase Rab5 and EEA1 (early
endosomal antigen 1), which promote fusion between
the SCV and empty vesicles formed during bacterial
invasion, creating a spacious habitat for Salmonella [32].
These early markers are quickly replaced by late endoso-
mal markers (Rab7, LAMP-1, LAMP-2 and LAMP-3)
and the vacuolar H
+-ATPase (V-ATPase), which
decreases the pH inside the SCV. Phagosome acidifica-
tion by the V-ATPase is related to the maturation of
lysosomes and the bactericidal function of lysosomal
hydrolases. SCV acidification is a key stimulus for Sal-
monella to express and assemble, intracellularly, the sec-
ond pathogenicity island-encoded T3SS (SPI-2 T3SS),
approximately three hours after infection [58]. One
study has revealed that SCV acidification in epithelial
cells containing Salmonella occurs more slowly than
in vacuoles containing heat-killed Salmonella or
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Apparently, this delay is independent of both Salmonella
T3SSs, yet the delayed acidification seems to allow the
bacteria to adapt to the new intracellular environment
by decreasing the activity of lysosomal hydrolases [59].
According to a recent report by Yu and colleagues
[60], the SPI-2 T3SS is assembled at the low pH of the
SCV, but secretion of a second set of effectors through
the SCV membrane depends on sensing the neutral pH
of the host cytosol. Effectors SseF and SseG colocalize
with the microtubule cytoskeleton and interfere with its
organization by inducing bundle formation. SseF and
SseG, together with SifA (see below), affect the microtu-
bule network and influence SCV positioning, helping to
guide the Salmonella towards the perinuclear region,
next to the Golgi complex [61,62]. This positioning
facilitates interaction of the SCV with the endocytic and
secretory pathways, allowing the pathogen to acquire
extra membrane for expansion of the SCV, and nutri-
ents to promote intracellular survival.
Four to six hours after entry, the SCV is characterized
by the presence of long membrane structures, called
Salmonella-induced filaments (Sifs) that extend from
the SCV. Sifs are enriched in lysosomal membrane gly-
coproteins such as LAMP-1, and their formation is
dependent on host cell microtubules [63]. These fila-
ments increase the size of SCVs by incorporating into
them PtdIns(3)P-enriched endosomes formed during
Salmonella entry but devoid of bacteria, and thus pro-
vide space for Salmonella to replicate. SseF and SseG
also somehow contribute to Sif formation, although to a
lesser extend than SifA [64].
During its maturation, the SCV interacts with host
endocytic-recycling regulators to regulate vacuole mem-
brane renewal [65]. The lipid composition of the SCV
m a yb em o d u l a t e db yt h eS P I - 2T 3 S Se f f e c t o rS s e J ,
which has a high degree of similarity to acyltransferases/
lipases and its enzymatic function is likely to oppose
that of SifA, down-regulating Sif formation [66]. In addi-
tion, the effectors SspH2 and SseI were observed to
colocalize with the F-actin cross-linkers filamin and pro-
filin, and are thus apparently involved with the dynamics
of the actin cytoskeleton around the SCV [67]. Actin
filaments in the vicinity of the SCV membrane are
assembled under the influence of the bacteria from
within the vacuole in an SPI-2 T3SS-dependent manner,
and seem to maintain the integrity of the vacuole and/
or recruit extra membrane that is necessary to increase
the membrane surface area to enclose the replicating
bacteria [68].
Inside the SCVs within phagocytes, the pathogen may
inhibit, in an SPI-2-dependent manner, production of
reactive oxygen species by preventing assembly of the
NADPH oxidase complex [69], and of reactive nitrogen
species by removing inducible nitric oxide synthase
from the vicinity of the SCV [70]. It is possible that the
actin meshwork and microtubule organization around
the SCV affect the trafficking of these enzymes by physi-
cally blocking their colocalization with the vacuole.
Both SPI-1 and SPI-2 T3SSs expressed by Salmonella
a r ea b l et oi n d u c em a c r o p h a g ed e a t h ,a l t h o u g hb yd i s -
tinct mechanisms and at different times of infection.
The SPI-1 T3SS effector protein SipB activates caspase-
1, triggering programmed pro-inflammatory cell death
(pyroptosis) within 45 minutes of infection. Alterna-
tively, macrophage death mediated by SipB may be sim-
ply a consequence of that effector’s ability to induce cell
lysis. Delayed macrophage death (up to 24 h) may occur
in an SPI-2 T3SS-dependent manner, although by a still
unknown mechanism [71]. Once activated, caspase-1
cleaves the inactive precursors of the cytokines interleu-
kin 1b (IL-1b) and interleukin 18 (IL-18) to their
mature, active forms. IL-1b and IL-18 are necessary to
trigger the intestinal inflammation response characteris-
tic of salmonellosis. Another pro-inflammatory cytokine
generated during the infection is IL-8, activated by
Cdc42 after it is activated by the SopE, SopE2 and/or
SopB effectors [30].
The inflammatory response generated against Salmo-
nella may compromise the intestinal barrier, allowing
bacteria to cross it and encounter the phagocytes that
have been attracted to the infection site. Once inside
phagocytes, the bacteria survive and replicate, and
some Salmonella species spread from Peyer’sp a t c h e s
to the mesenteric lymph nodes, creating a systemic
infection. Apoptosis of epithelial cells may also contri-
bute to the observed disintegration of the intestinal
epithelia in salmonellosis, since HT-29 human intest-
inal cells infected with S. dublin undergo delayed (not
earlier than 24 h p.i.) apoptosis preceded by caspase-3
activation, in a process dependent on effectors encoded
by the SPI-2 loci [72].
Although efficient colonization of the host is advanta-
geous for the pathogen, Salmonella appears to express
antivirulence modulators during systemic infection:
using a murine model, Gal-Mor et al. (2008) [73] have
shown that when Salmonella Typhimurium reaches the
intestinal tract, it expresses ZirT, an outer membrane
protein with a b-barrel conformation, which translocates
the protein ZirS; both proteins have been implicated in
reducing the bacterial load in the infected mice.
Shigella flexneri
Once internalized by M cells of the FAE, Shigella, unlike
Salmonella, disrupts the vacuole membrane in a process
dependent on the IpaB and IpaC invasins and escapes
into the host cell cytoplasm, where it proliferates. Once
present in the cytoplasm, the pathogen accumulates
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a “tail” that propels it through the cytoplasm and
enables it to invade neighboring epithelial cells. The
polymerization of actin depends on the action of IcsA
(intracellular spread A)/VirG, an outer membrane pro-
tein that has a polar distribution on the bacterial
surface.
IcsA/VirG recruits host cell cytoskeletal proteins; it
interacts with N-WASP and increases its affinity for
Arp2/3, forming the complex IcsA/N-WASP/Arp2/3
that induces actin nucleation. IcsA/VirG also recruits
vinculin, and although vinculin is not necessary for
movement of the pathogen, it may contribute to the
polymerization of actin. Moreover, actin depolymeriza-
tion factor (ADF)/cofilin, capping proteins and profilin
are recruited to stabilize the tail. Shigella intracellular
movement also depends on the tubulin-degrading activ-
ity of VirA, which opens the way through the microtu-
bule network for Shigella [38]. When the bacterium
eventually reaches the inner face of the basolateral
m e m b r a n eo ft h eh o s tc e l l ,af i n g e r - l i k ep r o t r u s i o ni s
formed which is endocytosed by a neighbouring epithe-
lial cell. Once endocytosed, the bacterium again escapes
from the vacuole, proliferates in the host cell cytoplasm
and invades new cells, thus advancing the course of dis-
ease. This process damages the tight junctions between
adjacent cells, damage that is worsened by altered
expression of tight junction-associated proteins induced
by the pathogen [12]. Disruption of the integrity of the
colonic mucosa leads to massive invasion of bacterial
cells by exposing the basolateral sides of colonocytes.
As a consequence of the tissue invasion, epithelial
cells start to produce a set of pro-inflammatory cyto-
kines such as IL-8, which together with the infecting
Shigella, strongly attracts polymorphonuclear (PMN)
cells from the sub-epithelial layer to the intestinal
lumen. The PMN infiltrate may exacerbate bacterial
invasion at an early stage, but it ultimately leads to reso-
lution of the infection, since the PMN cells do not allow
the pathogen to cross the FAE and spread into the
bloodstream. The negative consequences of PMN infil-
tration are severe inflammation and massive destruction
of the colonic mucosa, causing mucosal abscesses and
ulcers, the clinical characteristics of shigellosis [74].
After traversing M cells, Shigella exposes itself to an area
of the FAE intensively populated with macrophages and
dendritic cells. There, like Salmonella, it triggers macro-
phage pyroptosis: the translocated IpaB activates caspase-
1, which in turn cleaves IL-1b and IL-18 to their mature,
active forms [75]. Besides requiring membrane cholesterol
[76], activation of caspase-1 by IpaB appears to require
Ipaf, a Nod-like receptor localized on plasma and endoso-
mal membranes and implicated in bacterial recognition
[77]. IL-1b release causes rupture of the epithelial barrier,
enhancing bacterial dissemination, which in turn increases
inflammation and subsequent tissue destruction. Conver-
sely, the parallel release of IL-18, a potent interferon-g
inducer, aids host killing of Shigella by activated immune
cells, thus demonstrating a protective role in shigellosis
[78]. Shigella also secrete effectors through the T3SS that
are engaged in down-regulating inflammation and these
effectors may facilitate the early steps of infection. IpaH
and OspF accumulate in the nucleus: IpaH binds to U2AF,
a mammalian splicing factor, affecting the expression of
pro-inflammatory cytokines [79], and OspF dephosphori-
lates and inactivates MAPKs [80]. A third effector, OspG,
seems to prevent IBa degradation, so interfering with the
NF-B activation pathway.
Conclusions
Knowledge of the pathogenesis of diarrheal diseases due
to bacteria has grown greatly over the past two decades.
The study of the bacterial pathogens described in this
review has greatly illustrated the sophisticated mechan-
isms pathogens have developed to efficiently mimic and
manipulate several host signaling pathways. In conse-
quence, they succeed in colonizing the gut epithelium:
EPEC do so by adhering tightly to epithelial cells and
remaining extracellular; Salmonella, Shigella and Yersi-
nia, in contrast, invade the gut epithelium. While Salmo-
nella and Shigella are phagocytosed by macrophages and
provoke an inflammatory response that disrupts the
epithelial barrier, Yersinia avoids macrophage phagocyto-
sis and inhibits the host inflammatory response. In all
cases, the bacteria multiply and are able to leave the host
and be transmitted to another host. Understanding at the
molecular level of the systems developed by pathogenic
bacteria may allow us to target essential bacterial effec-
tors in novel therapeutic approaches to the infections.
On the other hand, the lack of epidemiological studies
identifying the predominant strain in a given endemic
region, and the fact that diarrheal diseases are not always
caused by a single etiological agent, certainly make such
approaches more difficult to put into practice.
Regardless of its direct clinical application, the study
of diarrheagenic bacteria as models of longstanding
host-pathogen interactions has revealed how eukaryotic
cells react under stress and how they mount an inflam-
matory response; such knowledge contributes to our
understanding of infectious diseases, and also of non-
infectious diseases. Moreover, the study of the diarrhea-
genic bacteria reviewed here has been giving new
approaches in the investigation of cellular microbiology
of other bacterial pathogens.
Appendix
1. Actin filaments (F-actin) are polymers of globular
actin (G-actin) that associate with other proteins to
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This net provides mechanical support for the cell mem-
brane and allows changes that generate lamellipodia,
filopodia and focal adhesion structures controlled by dif-
ferent members of the Rho GTPase family.
2. The family of NF-kB transcription factors is con-
trolled by the binding of an inhibitor protein, named
IkB, which sequesters monomers of NF-kB in the cyto-
plasm. NF-kB activation requires removal of the IkB
from the complex through the action of an IkB kinase
that phosphorylates the regulatory region of the inhibi-
tor. The phosphorylated IkB conjugates with ubiquitin
and is subsequently proteolytically degraded. Dimeric
NF-kB is then able to move to the nucleus and bind to
target DNA, thereby controlling the expression of a
wide range of genes involved in the inflammatory
response.
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